中西医结合治疗PCI术后心绞痛的研究进展

Advances in Integrated Traditional Chinese and Western Medicine for the Treatment of Angina Pectoris after PCI

摘要: 经皮冠状动脉介入治疗(PCI)是冠心病血运重建的主要手段，但术后仍有相当比例患者复发心绞痛，影响生活质量及远期预后。现代西医在急性期管理中手段明确、起效迅速，但对微血管病变疗效有限，长期用药存在耐药性与不良反应等问题。中医可通过整体调节与多靶点干预发挥协同增效作用。近年来，中西医结合治疗PCI术后心绞痛的临床研究日益增多，大量随机对照试验证实，在常规西药基础上联合中医治疗可以更好地发挥各自的优势，提高治疗效果。本文从中西医结合临床研究进展进行系统综述，以期为临床实践优化和后续研究提供参考。

Abstract: Percutaneous coronary intervention (PCI) is the primary revascularization strategy for coronary heart disease; however, a considerable proportion of patients still experience recurrent angina after the procedure, which adversely affects their quality of life and long-term prognosis. Modern Western medicine offers clear and rapidly effective management in the acute phase, but its efficacy is limited for microvascular disease, and long-term use is associated with issues such as drug resistance and adverse reactions. Traditional Chinese medicine (TCM) can exert synergistic effects through holistic regulation and multi-target intervention. In recent years, clinical studies on integrated traditional Chinese and Western medicine for treating post-PCI angina have been increasing. Numerous randomized controlled trials have confirmed that combining TCM therapies with conventional Western medications can better leverage the respective advantages of both approaches and improve treatment outcomes. This article provides a systematic review of the clinical research progress in integrated traditional Chinese and Western medicine, aiming to offer references for optimizing clinical practice and guiding future investigations.